Olanzapine Tablet, Orally Disintegrating
Product Images NDC 59746-307

This is a package for CADISTAY, which contains 30 tablets of Olanzapine Orally Disintegrating Tablets, USP, 10mg each. The pharmacist should dispense the medication guide to each patient. The dosage and usage information is included in the prescribing information. The package contains a warning to keep the medication out of children's reach, and store the medication between 20°C-28°C, with excursions permitted between 15°C-20°C. There is a note to not open the blister until immediately prior to use. The package also contains the manufacturer's address.*

This is a description of the medication package for CADISTAY Olanzapine Orally Disintegrating Tablets, USP 15mg. The package details the drug's NDC number, dosage, and usage instructions, as well as directions for storage to protect the medication from light and moisture. The package also comes with a medication guide to be given to patients. The text warns that this medication contains phenylalanine and should be kept out of reach of children.*

This is a description for a medication labeled NDC 59746-309-32. The medication is called Cadistay and is comprised of Olanzapine, which is contained in Orally Disintegrating Tablets, USP. Each box contains 30 Tablets, with each unit-dose consisting of 20 mg of Olanzapine. The package comes with instructions to be given to each patient, and a warning that the medication contains phenylalanine, which may be harmful to individuals with phenylketonuria. The medication should be kept out of reach of children, stored at a temperature of 15°C-30°C (89°F-86°F) with protection from light and moisture. The medication is manufactured by Cadistay JubisaniCadit Pramsceutcats in Selsbuny, MD 21801, USA. The blister should not be opened until prior to use.*

The text refers to Cadista's Olanzapine Orally Disintegrating Tablets, USP, with a concentration of 5mg per tablet, for prescription-only use. The tablets come in blister packs of 30, with 10 unit doses per blister. The accompanying medication guide must be given to each patient by the pharmacist. The text also provides instructions regarding phenylalanine content, dosage and use, storage, and handling of the medication, and includes contact information for Cadista.*